NC
ALXN

Nexthera Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Nexthera Capital’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-132,623
Closed -$16.5M – 71
2018
Q2 		$16.5M Buy
+132,623
New +$15.5M 2.55% 11
2017
Q4 		– Sell
-62,337
Closed -$7.59M – 54
2017
Q3 		$8.74M Sell
62,337
-57,663
-48% -$7.83M 2.25% 15
2017
Q2 		$14.6M Buy
120,000
+33,500
+39% +$3.9M 6.36% 3
2017
Q1 		$10.5M Sell
86,500
-13,500
-14% -$1.74M 5.35% 7
2016
Q4 		$12.2M Buy
+100,000
New +$12.2M 7.17% 4

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nexthera Capital's ALXN Position: Q3 2018 in Review

Nexthera Capital sold out of Alexion Pharmaceuticals (ALXN) in Q3 2018, closing a stake of 132,623 shares — an estimated $16.5M sold.

Nexthera Capital first reported a position in ALXN in Q4 2016 and held it in 5 quarters. The position peaked at $16.5M in Q2 2018. 584 funds tracked by Wall St. Rank hold ALXN as of Q3 2018.

  • Nexthera Capital reported no remaining Alexion Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Nexthera Capital sold 132,623 Alexion Pharmaceuticals shares in Q3 2018, an estimated $16.5M.
  • Nexthera Capital first reported a position in Alexion Pharmaceuticals in Q4 2016 and held it in 5 quarters.
  • Nexthera Capital's Alexion Pharmaceuticals position peaked at $16.5M in Q2 2018.
  • 584 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2018.

Based on Nexthera Capital's 13F filing for Q3 2018, filed 14 Nov 2018.